Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations

• Main Authors: Tan, P.S, Bilger, M, Lopes, G.L, Acharyya, S, Haaland, B
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: afatinib; antineoplastic agent; bevacizumab; cetuximab; conatumumab; epidermal growth factor receptor; erlotinib; gefitinib; necitumumab; pemetrexed; tumor marker; Article; cancer combination chemotherapy; cancer survival; drug efficacy; EGFR gene; gene; gene mutation; histology; human; meta analysis; non small cell lung cancer; outcome assessment; overall survival; patient selection; personalized medicine; priority journal; progression free survival; squamous cell lung carcinoma; survival analysis; survival rate; survival time; Bayes theorem; cancer staging; genetics; induction chemotherapy; lung tumor; maintenance chemotherapy; metastasis; mortality; mutation; prognosis; proto oncogene; treatment outcome; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Genes, erbB-1; Humans; Induction Chemotherapy; Lung Neoplasms; Maintenance Chemotherapy; Mutation; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Treatment Outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/178723
• Institution: National University of Singapore

10.1002/cam4.1101